The impact of antimicrobial resistance on health and economic outcomes.
By S. Cosgrove, Yehuda Carmeli. Clinical Infectious Diseases, 2003
635 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, General Health Professions, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/9dad62a1bde07e12135713c0721f12d2a307ddb5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In General Health Professions
In Molecular Medicine
Citations in the corpus
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (2007, background): “and mortality, as well as increased health care costs [32, 33].”
- Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship (2007, background): “and mortality, as well as increased health care costs [32, 33].”
- The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (2006, methodology): “The types of outcomes examined, the perspective of the study, the reference groups within the study, adjustments for confounding factors, and the type of economic assessment are among the factors that should be considered (table 1) [2].”
- Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications (2018, background): “less efficacious but more toxic antibacterial agents, and receive broad-spectrum antibacterial agents, which are so-called reserved or last resorts as an empirical antibiotic regimen [132].”
- Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 (2007, neutral): “Several studies have estimated that antimicrobial drug–resistant infections increase death, illness, and direct costs by 30%–100% (30).”
- Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. (2009, methodology): “Decisions on the best way to spend or invest current limited resources depend on whose point of view is considered [27–29].”
- PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings (2004, neutral): “[7] [8] [9] A rapid reliable diagnostic assay, which allows for accurate identification of infected patients and informed early therapeutic intervention, would thus be invaluable for emergency and critical care physicians.”
- Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact (2006, background): “It limits therapeutic options and leads to increased mortality and morbidity (6).”